PF-Atlas › Clinical Trials › NCT02035488
Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
Tobramycin · Phase 1
Registry ID
NCT02035488
Phase
Phase 1
Status
Completed
Drug / intervention
Tobramycin
Sponsor
University Medical Center Groningen
Start
2013-10
About this trial
Tobramycin is evaluated in NCT02035488, a Phase 1 idiopathic pulmonary fibrosis study sponsored by University Medical Center Groningen. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT02035488 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.